Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins

Neurotoxicity Research

Volumn 11, Issue 3-4, 2007, Pages 169-182

  Herrera Marschitz, Mario ^a   Bustamante, Diego ^a   Morales, Paola ^a   Goiny, Michel ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amphetamine; Apomorphine; Basal ganglia; Microdialysis; Rat; Rotational behaviour

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4,6,6A,7,8,12B HEXAHYDRO 7 METHYLINDOLO[4,3 AB]PHENANTHRIDINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 PHENYLTHEOPHYLLINE; AMPHETAMINE; APOMORPHINE; BENZATROPINE; BROMOCRIPTINE; CAFFEINE; DEXAMPHETAMINE; DOPA; DOPAMINE; DOPAMINE RECEPTOR; INDATRALINE; LISURIDE; MEMANTINE; NEUROTOXIN; NIALAMIDE; NOMIFENSINE; PARGYLINE; PERGOLIDE; PIRIBEDIL; PRECLAMOL; PROPYLNORAPOMORPHINE; QUINPIROLE; SULPIRIDE; TALIPEXOLE; THEOBROMINE; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DRUG SCREENING; MICRODIALYSIS; MONOAMINERGIC SYSTEM; MOTOR SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOTAXIS; SYNAPSE; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; DRUG EFFECT; HEMISPHERIC DOMINANCE; HISTOLOGY; HISTORY; HUMAN; METABOLISM; NERVE CELL NETWORK; PHYSIOLOGY; REVIEW;

RATTUS;

ANIMALS; BASAL GANGLIA; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; HISTORY, 20TH CENTURY; HUMANS; NERVE NET; NEUROTOXINS; RECEPTORS, DOPAMINE;

EID: 34548426452     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033566     Document Type: Article

References (95)

1. Adams RN (1978) In vivo electrochemical recording - a new neurophysiological approach. Trends Neurosci. 1, 160-163.
2. Agnati LF, K Fuxe, M Zoli, I Ozini, A Härfstrand, G Toffano and F Ferraguti (1986) A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immu-noreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: The volume transmission and the wiring transmission. Acta Physiol. Scand. 128, 201-207.
3. Andén N-E, A Carlsson, A Dahlstr̈m, K Fuxe, N-Å Hillarp and K Larsson (1964) Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3, 523-530.
4. Andén N-E, A Dalhström, K Fuxe and K Larsson (1966) Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol. Toxicol. 24, 264-274.
5. Andén N-E, A Rubenson, K Fuxe and T Hökfelt (1967) Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627-629.
6. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol. 62, 121-130.
7. Bentivoglio M and M Morelli (2005) The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain, In: HOndbook of Chemical Neuroanatomy:Dopamine (Björklund A and T Hökfelt, Eds.) (Elsevier BV:THe Netherlands), Vol. 21, 1-107.
8. 2 dopamine receptor cDNA. Nature 336, 781-783.
9. Campbell GA, MJ Eckardt and FF Weight (1985) Dopaminergic mechanisms in subthalamic nucleus of rat: Analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333, 261-270.
10. Carlsson A, K Fuxe, B Hamberger and M Lindqvist (1966) Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol. Scand. 67, 481-497.
11. Chevalier G, AM Tierry, T Shibazaki and J Feger (1981) Evidence for a GABAergic inhibitory nigrotectal pathway in the rat. Neurosci. Lett. 21, 67-70.
12. Christensson-Nylander I, M Herrera-Marschitz, W Staines, T Hökfelt, L Terenius, U Ungerstedt, C Cuello, WH Oerteland M Goldstein (1986) Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohisto-chemical evidence. Exp. Brain Res. 64, 169-192.
13. Corrodi H, K Fuxe, T Hökfelt, P Lidbrink and U Ungerstedt (1973) Effect of ergot drugs on central catecholamine neurons: Evidence for stimulation of dopamine neurons. J. Pharm. Pharmacol. 25, 409-412.
14. Cuello AC and G Paxinos (1978) Evidence for a long leuenkephalin striatopallidal pathway in rat brain. Nature 271, 178-180.
15. Dahlström A and K Fuxe (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 232, 1-55.
16. Dahlström A and K Fuxe (1965) Evidence for the existence of monoamine-containing neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta Physiol. Scand. Suppl. 247, 1-36.
17. 1 dopamine receptor. Nature 347, 72-76.
18. Delgado JMR, FV De Feudis, RH Roth, DK Ryugo and BM Mitruka (1972) Dialytrode for long-term intracerebral perfusion in awake monkeys. Arch. Int. Pharmacodyn. 198, 9-21.
19. 3 receptor in the rat brain. Neuroscience 65, 731-745.
20. DiChiara G, M Olianas, M Del Fiaco, PF Spano and A Tagliamonte (1977) Intranigral kainic acid is evidence that nigral non-dopaminergic neurons control posture. Nature 268, 743-745.
21. DiChiara G, ML Porceddu, M Morelli, ML Mulas and GL Gessa (1979) Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res. 176, 273-284.
22. Ernst AM (1967) Mode of action of apomorphine and dexamphet-amine on gnawing compulsion in rats. Psychopharmacology 10, 316-323.
23. Ferre S, WT O'Connor, K Fuxe and U Ungerstedt (1993) The striato-pallidal neuron: A main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13, 5402-5406.
24. Fuxe K and U Ungerstedt (1970) Histochemical biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration, In: Amphetamine and Related Compounds (Costa E, Ed.) (Raven Press:NEw York), pp 257-288.
25. Gaddum JH (1961) Push-pull cannulae. J. Physiol. (London) 155, 1-2.
26. Garcia-Munoz M, NM Nicolaou, IF Tulloch, AK Wright and GW Arbuthnott (1977) Feedback loop or output pathway in striato-nigral fibers? Nature 265, 363-365.
27. Gerfen CR and CJ Wilson (1996) The basal ganglia. Chapter II, In: Handbook of Chemical Neuroanatomy, Vol 12: Integrated Systems of the CNS. Part III (Swanson LW, A Björklund and T Hökfelt, Eds.) (Elsevier Science BV: The Netherlands), pp 371-468.
28. Glowinski J (1974) Properties and function of intraneuronal monoamine compartments in central aminergic neurons, In: Handbook of Psychopharmacology (Iversen LL, S Iversen and SH Snyder, Eds.) (Plenum Press:NEw York), pp 139-167.
29. Goldstein M, A Lieberman, JY Lew, T Asano, MR Rosenfeld and MH Makman (1980) Interaction of pergolide with central dopaminergic receptors. Proc. Natl. Acad. Sci. USA 77, 3725-3728.
30. Haber SN, HJ Groenewegen, EA Grove and WJH Nauta (1985) Efferent connections of the ventral pallidum: Evidence of a dual striato pallidofugal pathway. J. Comp. Neurol. 235, 322-335.
31. Hallman H and G Jonsson (1984) Studies on central dopamine neurons. Regional characterization of dopamine turnover. Med. Biol. 62, 198-209.
32. Herrera-Marschitz M (1986) Neuropharmacology and functional anatomy of the basal ganglia. Karolinska Institutet-Thesis, Stockholm, pp 1-79.
33. 2 receptor sites. Eur. J. Pharmacol. 98, 165-176.
34. Herrera-Marschitz M and U Ungerstedt (1984b) Evidence striatal efferents relate to different dopamine receptors. Brain Res. 323, 269-278.
35. Herrera-Marschitz M and U Ungerstedt (1985) Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxydo-pamine denervated rats. Eur. J. Pharmacol. 109, 349-354.
36. Herrera-Marschitz M, J Hyttel and U Ungerstedt (1984) The dopamine D-1 antagonist SCH 23390 inhibits apomorphine but not pergolide induced rotation. Acta Physiol. Scand. 122, 427-428.
37. Herrera-Marschitz M, T Ḧkfelt and U Ungerstedt (1985a) A rotational model sensitive to D-1 but not to D-2 dopamine receptor stimulation. Acta Physiol. Scand. (Suppl. 124), 542, 181.
38. Herrera-Marschitz M, C Forster and U Ungerstedt (1985b) Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxydopamine-lesioned rats. I: Comparisons between systemic and intrastriatal injections. Acta Physiol. Scand. 125, 519-527.
39. Herrera-Marschitz M, H Utsumi and U Ungerstedt (1990) Scoliosis in rats with experimentally-induced hemiparkin-sonism: Dependence upon striatal dopamine denervation. J. Neurol. Neurosurg. Psychiatr. 53, 39-43.
40. Herrera-Marschitz M, JJ Meana, WT O'Connor, M Goiny, MS Reid and U Ungerstedt (1992) Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis, reciprocal interactions. Amino Acids 2, 157-179.
41. Herrera-Marschitz M, Z-B You, M Goiny, JJ Meana, R Silveira, O Godukhin, Y Chen, S Espinoza, E Pettersson, F Loidl, G Lubec, K Andersson, I Nylander, L Terenius and U Ungerstedt (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis. J. Neurochem. 66, 1726-1735.
42. Herrera-Marschitz M, M Goiny, Z-B You, JJ Meana, E Pettersson, R Rodriguez-Puertas, Z-Q Xu, L Terenius, T Hökfelt and U Ungerstedt (1997) On the release of glutamate and aspartate in the basal ganglia of the rat: Interactions with monoamines and neuropeptides. Neurosci. Biobehav. Rev. 21, 489-495.
43. Hopkins DA and LW Niessen (1976) Substantia nigra projections to the reticulata formation, superior colliculus and central gray in the rat, cat and monkey. Neurosci. Lett. 2, 253-259.
44. +. Life Sci. 45, 283-293.
45. Hyttel J (1983) SCH 23390- the first selective dopamine D-1 antagonist. Eur. J. Pharmacol. 91, 153-154.
46. Hyttel J (1986) Dopamine D-1 and D-2 receptors. Characterization and differential effects of neuroleptics. Acta Pharm. Suecica Suppl. 1, 426-439.
47. Hökfelt T and U Ungerstedt (1973) Specificity of 6-hydroxy-dopamine induced degeneration of central monoamine neurons: An electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res. 60, 269-297.
48. Imperato S and G DiChiara (1984) Trans-striatal dialysis coupled to reverse performance liquid chromatography with electrochemical detection: A new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4, 960-977.
49. Iorio LC, A Barnett, FH Leitz, VP Houser and CA Korduba (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226, 462-468.
50. Jones DL and GJ Mogenson (1980) Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol. 238, 65-69.
51. Jonsson G, H Hallman, I Mefford and RN Adams (1980) The use of liquid chromatography with electrochemical detection for the determination of adrenaline and other biogenic- monoamines in the CNS, In: Central Adrenaline Neurons (Fuxe K, M Goldstein, B Hökfelt and T Hökfelt, Eds.) (Pergamon Press:OXford-New York), pp 59-71.
52. Kilpatrick IC, MS Starr, A Flechter, TA James and NK MacLeod (1980) Evidence for a GABAergic nigrothalamic pathway in the rat. Exp. Brain Res. 40, 45-54.
53. Kilpatrick IC, GL Collingridge and MS Starr (1982) Evidence for the participation of nigrotectal γ-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat. Neuroscience 7, 207-222.
54. Kita H, HT Chang and ST Kitai (1983) Pallidal inputs to sub-thalamus: intracellular analysis. Brain Res. 264, 255-265.
55. Kretschmer BD, M Goiny and M Herrera-Marschitz (2000) Effect of intracerebral administration of NMDA and AMPA on dopamine and glutamate release in the ventral pallidum on motor behaviour. J. Neurochem. 74, 2049-2057.
56. Langer SZ (1966) The degeneration contraction of the nictitating membrane in the un-anesthetized cat. J. Pharmacol. Exp. Ther. 151, 66-72.
57. Loopuijt LD and D Van Der Kooy (1985) Organization of the striatum: collateralization of its efferent axons. Brain Res. 348, 86-99.
58. Marshall JF and U Ungerstedt (1977) Striatal efferent fibers play a role in maintaining rotational behaviour in the rat. Science 198, 62-64.
59. Mogenson GJ and MA Nielsen (1983) Evidence that an accumbens to subpallidal GABAergic projection contributes to locomotor activity. Brain Res. Bull. 11, 309-314.
60. 1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA 87, 6723-6727.
61. Osborne PG, WT O'Connor, KL Drew and U Ungerstedt (1990) An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and anesthetised rats. J. Neurosci. Meth. 34, 99-105.
62. Paxinos G and C Watson (1982) The Rat Brain in Stereotaxic Coordinates (Academic Press: San Diego, CA).
63. Pendleton RG, L Samler, C Kaiser and PT Ridley (1978) Studies on renal dopamine receptors with a new agonist. Eur. J. Pharmacol. 51, 19-28.
64. Pycock CK and CD Marsden (1978) The rotating rodent: A two component system? Eur. J. Pharmacol. 47, 167-175.
65. Reid M, M Herrera-Marschitz, T Hökfelt, L Terenius and U Ungerstedt (1988) Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. Eur. J. Pharmacol. 147, 411-420.
66. Reid M, M Herrera-Marschitz, T Hökfelt, N Lindefors, H Persson and U Ungerstedt (1990) Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of striatal dopamine: Evidence for direct regulatory mechanisms. Exp. Brain Res. 82, 293-303.
67. Robertson HA (1992) Dopamine receptor interactions: Some implications for the treatment of Parkinson's disease. Trends Neurosci. 15, 201-206.
68. Romero CA, DA Bustamante, G Zapata-Torres, M Goiny, B Cassels and M Herrera-Marschitz (2006) Neurochemical and behavioural characterization of alkoxyamphetamine derivatives in rats. Neurotoxicity Res. 10, 11-22.
69. Rouzaire-Dubois B, C Hammond, B Hamon and J Ferger (1980) Pharmacological blockade of the globus pallidus-induced inhibitory response of subthalamic cells in the rat. Brain Res. 200, 321-329.
70. Schwarcz R, K Fuxe, LF Agnati, T Hökfelt and JT Coyle (1979a) Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors. Brain Res. 170, 485-495.
71. Schwarcz R, T Hökfelt, K Fuxe, G Jonsson, M Goldstein and L Terenius (1979b) Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study. Exp. Brain Res. 37, 199-216.
72. Seeman P (1981) Brain dopamine receptors. Pharmacol. Rev. 32, 229-313.
73. Temlett JA, NP Quinn, PG Jenner, CD Marsden, E Purcher, AM Bonnet, Y Agid, R Markstein and X Lataste (1989) Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Mov. Disord. 4, 261-265.
74. Trabucchi M, R Longoni, S Fresia and PF Spano (1975) Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrain. Life Sci. 17, 1551-1556.
75. Tranzer JP and H Thoenen (1968) An electron microscopic study of selective, acute degeneration of sympathetic erve terminals after administration of 6-hydroxydopamine. Experientia 24, 155-156.
76. 2 dopamine receptor. Nature 292, 463-465.
77. Ungerstedt U (1971a) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol. Scand. Suppl. 367, 1-48.
78. Ungerstedt U (1971b) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367, 69-93.
79. Ungerstedt U (1971c) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. Suppl. 367, 49-68.
80. Ungerstedt U (1976) 6-Hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: The turning syndrome. Pharmacol. Ther. Behav. 2, 37-40
81. Ungerstedt U (1991) Microdialysis - principles and applications for studies in animals and man. J. Intern. Med. 230, 365-373.
82. Ungerstedt U and GW Arbuthnott (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 85-493.
83. Ungerstedt U and M Herrera-Marschitz (1981) Behavioural pharmacology of dopamine receptor mechanisms, In: Chemical Neurotransmission 75 years (Stjärne L, P Hedqvist, H Lagercrantz and Å Wennmalm, Eds.) (Academic Press:NEw York), pp 481-494.
84. Ungerstedt U and C Pycock (1974) Functional correlates of dopamine neurotransmission. Bull. Schweiz. Acad. Med. Wiss. 1278, 1-5.
85. Ungerstedt U, M Herrera-Marschitz, U Jungnelius, L Ståhle, U Tossman and T Zetterström (1982) Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis. Adv. Biosci. 37, 219-231.
86. Van Der Kooy D, T Hattori, K Shannak and O Hornykiewicz (1981) The pallido-subthalamic projection in rat: Anatomical and biochemical studies. Brain Res. 204, 253-240.
87. Vincent SR, T Hattori and EG McGeer (1978) The nigrotectal projection: A biochemical and ultrastructural characterization. Brain Res. 151, 159-164.
88. Westerink BHC, HM Hofsteed, G Damsma and GB de Vries (1988) The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats evaluated by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 373-378.
89. You Z-B, M Herrera-Marschitz, E Brodin, JJ Meana, P Morino, T Hökfelt, R Silveira, M Goiny and U Ungerstedt (1994a) On the origin of striatal cholecystokinin release: Studies with in vivo microdialysis. J. Neurochem. 62, 76-85.
90. + -depolarization, lesions and peptidase inhibition. Neuroscience 63, 415-425.
91. 2 receptor agonists. Neuroscience 63, 427-434.
92. Zetterström T (1986) Pharmacological analysis of central dopaminergic neurotransmission using a novel in vivo brain perfusion method. Karolinska Institutet-Thesis, Stockholm, pp 1-45.
93. Zetterström T, T Sharp, CA Marsden and U Ungerstedt (1983) In vivo measurement of dopamine and its metabolites studied by intracerebral dialysis: Changes after D-amphetamine. Neurochem. 41, 1769-1773.
94. Zetterström T, M Herrera-Marschitz and U Ungerstedt (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376, 1-7.
95. 1 dopamine receptors. Nature 347, 76-80.